Respiratory syncytial virus infection provides protection against severe acute respiratory syndrome coronavirus challenge
Journal of Virology · 2024
DOI: 10.1128/jvi.00669-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Virology, 2024. Verfasst von Stacey M Hartwig und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of Iowa, Iowa City, Iowa, USA. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, COVID-19, Mice, Inbred BALB C, SARS-CoV-2. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
Respiratory infections are a major health burden worldwide. Respiratory syncytial virus (RSV) is among the leading causes of hospitalization in both young children and older adults. The onset of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic and the public health response had a profound impact on the normal seasonal outbreaks of other respiratory viruses. However, little is known about how a prior respiratory virus infection impacts SARS-CoV-2 disease outcomes. In this study, we examine the impact of a previous RSV infection on the disease severity of a subsequent SARS-CoV-2 challenge in BALB/c mice. Mice infected with RSV, followed by a SARS-CoV-2 challenge, 30 days later, exhibited decreased weight loss and increased survival as compared to control groups. Our results suggest a prior RSV infection can provide protection against a subsequent SARS-CoV-2 infection. IMPORTANCE Severe acute respiratory syndrome coronavirus 2 and respiratory syncytial virus are respiratory viruses that are a major health burden worldwide. Severe acute respiratory syndrome coronavirus 2 and respiratory syncytial virus frequently have peak seasonal outbreaks during the winter months, and are capable of causing severe respiratory disease, often leading to hospitalization. The 2019 pandemic brought attention to the importance of understanding how co-circulating viruses can impact the disease severity of other respiratory viruses. It is known that many hospitalized patients are undergoing multiple viral infections at once, yet not much has been studied to understand the impact this has on other respiratory viruses or patients. How co-circulating viruses impact one another can provide critical knowledge for future interventions of hospitalized patients and potential vaccination strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, University of Iowa, Iowa City, Iowa, USA.
- Department of Pathology, University of Iowa, Iowa City, Iowa, USA.
- Interdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, Iowa, USA.
ORCID-Profile: Stacey M Hartwig, Lok-Yin Roy Wong, Stanley Perlman, Steven M Varga
Förderung
- NIAID NIH HHS
Zitieren
APA
Hartwig, S. M., Odle, A., Wong, L. Y. R., Meyerholz, D. K., Perlman, S., & Varga, S. M. (2024). Respiratory syncytial virus infection provides protection against severe acute respiratory syndrome coronavirus challenge. Journal of Virology. https://doi.org/10.1128/jvi.00669-24
Vancouver
Hartwig SM, Odle A, Wong LYR, Meyerholz DK, Perlman S, Varga SM. Respiratory syncytial virus infection provides protection against severe acute respiratory syndrome coronavirus challenge. Journal of Virology. 2024. doi:10.1128/jvi.00669-24
BibTeX
@article{Hartwig2024,
author = {Hartwig, Stacey M and Odle, Abby and Wong, Lok-Yin Roy and Meyerholz, David K and Perlman, Stanley and Varga, Steven M},
title = {Respiratory syncytial virus infection provides protection against severe acute respiratory syndrome coronavirus challenge},
journal = {Journal of Virology},
year = {2024},
doi = {10.1128/jvi.00669-24}
}
EUVIMED